United Therapeutics (NASDAQ: UTHR) CFO exercises options and sells 10k shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

United Therapeutics CFO and Treasurer James Edgemond exercised stock options for 10,000 shares of common stock at an exercise price of $135.42 per share, then sold 10,000 shares in a series of open-market trades at prices generally around $582–$607 per share.

After these transactions, he directly owns 18,876 shares of common stock and holds 132,500 stock options. The exercise and subsequent sales were carried out under a pre-arranged Rule 10b5-1 trading plan entered into on October 31, 2025, indicating the trades were scheduled in advance.

Insider Trade Summary 10b5-1

Net Seller: 10,000 shares ($5,931,683)

Net Sell 24 txns

Insider EDGEMOND JAMES

Role CFO AND TREASURER

Sold 10,000 shs ($5.93M)

Type	Security	Shares	Price	Value
Exercise	Stock Option	10,000	$0.00	--
Exercise	Common Stock	10,000	$135.42	$1.35M
Sale	Common Stock	40	$581.73	$23K
Sale	Common Stock	120	$583.5233	$70K
Sale	Common Stock	120	$585.1713	$70K
Sale	Common Stock	437	$586.2736	$256K
Sale	Common Stock	860	$587.3541	$505K
Sale	Common Stock	1,487	$588.4159	$875K
Sale	Common Stock	1,196	$589.2341	$705K
Sale	Common Stock	1,026	$590.3644	$606K
Sale	Common Stock	481	$591.2584	$284K
Sale	Common Stock	120	$592.12	$71K
Sale	Common Stock	176	$593.6848	$104K
Sale	Common Stock	480	$594.7366	$285K
Sale	Common Stock	500	$595.9143	$298K
Sale	Common Stock	204	$596.7409	$122K
Sale	Common Stock	240	$597.719	$143K
Sale	Common Stock	200	$598.8305	$120K
Sale	Common Stock	790	$599.8249	$474K
Sale	Common Stock	212	$601.4262	$128K
Sale	Common Stock	417	$602.5307	$251K
Sale	Common Stock	103	$603.6921	$62K
Sale	Common Stock	770	$604.64	$466K
Sale	Common Stock	21	$606.53	$13K

Holdings After Transaction: Stock Option — 132,500 shares (Direct); Common Stock — 28,876 shares (Direct)

Footnotes (1)

This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. This transaction was executed in multiple trades at prices ranging from $592.02 to $592.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $593.07 to $594.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $594.24 to $595.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $595.38 to $596.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $596.41 to $597.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $597.50 to $598.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $598.50 to $599.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $599.76 to $600.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $600.95 to $601.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $602.06 to $603.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $583.31 to $583.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $603.63 to $603.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $584.69 to $585.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $585.84 to $586.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $586.85 to $587.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $587.85 to $588.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $588.85 to $589.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $589.85 to $590.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $590.85 to $591.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Options exercised: 10,000 shares Exercise price: $135.42 per share Shares sold: 10,000 shares +4 more

7 metrics

Options exercised 10,000 shares Stock options exercised into common stock

Exercise price $135.42 per share Stock option exercise price

Shares sold 10,000 shares Total open-market sales reported

Sale price range ≈$581.73–$606.53 per share Approximate range across multiple sale trades

Shares owned after 18,876 shares Direct common stock holdings post-transaction

Options outstanding after 132,500 options Stock options held after the exercise

Rule 10b5-1 plan date October 31, 2025 Date trading plan was entered

Key Terms

Rule 10b5-1 trading plan, Stock Option, open-market sale, weighted average price, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Stock Option financial

"security_title: "Stock Option" with underlying security title "Common Stock""

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

open-market sale financial

"transaction_action: "open-market sale" for multiple Common Stock transactions"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

weighted average price financial

"The price reported above reflects the weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

derivative exercise/conversion financial

"transaction_action: "derivative exercise/conversion" for the option exercise"

Form 4 Insider Transactions: What Each Field Means →

03/31/2026 - 04:32 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

EDGEMOND JAMES

(Last)

(First)

(Middle)

C/O UNITED THERAPEUTICS CORPORATION

1000 SPRING STREET

(Street)

SILVER SPRING

MARYLAND

20910

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITED THERAPEUTICS Corp [ UTHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CFO AND TREASURER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/30/2026		M⁽¹⁾		10,000	A	$135.42	28,876	D
Common Stock	03/30/2026		S⁽¹⁾		40	D	$581.73	28,836	D
Common Stock	03/30/2026		S⁽¹⁾		120	D	$583.5233⁽²⁾	28,716	D
Common Stock	03/30/2026		S⁽¹⁾		120	D	$585.1713⁽³⁾	28,596	D
Common Stock	03/30/2026		S⁽¹⁾		437	D	$586.2736⁽⁴⁾	28,159	D
Common Stock	03/30/2026		S⁽¹⁾		860	D	$587.3541⁽⁵⁾	27,299	D
Common Stock	03/30/2026		S⁽¹⁾		1,487	D	$588.4159⁽⁶⁾	25,812	D
Common Stock	03/30/2026		S⁽¹⁾		1,196	D	$589.2341⁽⁷⁾	24,616	D
Common Stock	03/30/2026		S⁽¹⁾		1,026	D	$590.3644⁽⁸⁾	23,590	D
Common Stock	03/30/2026		S⁽¹⁾		481	D	$591.2584⁽⁹⁾	23,109	D
Common Stock	03/30/2026		S⁽¹⁾		120	D	$592.12⁽¹⁰⁾	22,989	D
Common Stock	03/30/2026		S⁽¹⁾		176	D	$593.6848⁽¹¹⁾	22,813	D
Common Stock	03/30/2026		S⁽¹⁾		480	D	$594.7366⁽¹²⁾	22,333	D
Common Stock	03/30/2026		S⁽¹⁾		500	D	$595.9143⁽¹³⁾	21,833	D
Common Stock	03/30/2026		S⁽¹⁾		204	D	$596.7409⁽¹⁴⁾	21,629	D
Common Stock	03/30/2026		S⁽¹⁾		240	D	$597.719⁽¹⁵⁾	21,389	D
Common Stock	03/30/2026		S⁽¹⁾		200	D	$598.8305⁽¹⁶⁾	21,189	D
Common Stock	03/30/2026		S⁽¹⁾		790	D	$599.8249⁽¹⁷⁾	20,399	D
Common Stock	03/30/2026		S⁽¹⁾		212	D	$601.4262⁽¹⁸⁾	20,187	D
Common Stock	03/30/2026		S⁽¹⁾		417	D	$602.5307⁽¹⁹⁾	19,770	D
Common Stock	03/30/2026		S⁽¹⁾		103	D	$603.6921⁽²⁰⁾	19,667	D
Common Stock	03/30/2026		S⁽¹⁾		770	D	$604.64	18,897	D
Common Stock	03/30/2026		S⁽¹⁾		21	D	$606.53	18,876	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option	$135.42	03/30/2026		M⁽¹⁾			10,000	03/15/2023	03/15/2027	Common Stock	10,000	$0.00	132,500	D

Explanation of Responses:

1. This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.

2. This transaction was executed in multiple trades at prices ranging from $583.31 to $583.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. This transaction was executed in multiple trades at prices ranging from $584.69 to $585.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

4. This transaction was executed in multiple trades at prices ranging from $585.84 to $586.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

5. This transaction was executed in multiple trades at prices ranging from $586.85 to $587.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

6. This transaction was executed in multiple trades at prices ranging from $587.85 to $588.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

7. This transaction was executed in multiple trades at prices ranging from $588.85 to $589.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

8. This transaction was executed in multiple trades at prices ranging from $589.85 to $590.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

9. This transaction was executed in multiple trades at prices ranging from $590.85 to $591.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

10. This transaction was executed in multiple trades at prices ranging from $592.02 to $592.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

11. This transaction was executed in multiple trades at prices ranging from $593.07 to $594.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

12. This transaction was executed in multiple trades at prices ranging from $594.24 to $595.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

13. This transaction was executed in multiple trades at prices ranging from $595.38 to $596.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

14. This transaction was executed in multiple trades at prices ranging from $596.41 to $597.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

15. This transaction was executed in multiple trades at prices ranging from $597.50 to $598.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

16. This transaction was executed in multiple trades at prices ranging from $598.50 to $599.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

17. This transaction was executed in multiple trades at prices ranging from $599.76 to $600.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

18. This transaction was executed in multiple trades at prices ranging from $600.95 to $601.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

19. This transaction was executed in multiple trades at prices ranging from $602.06 to $603.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

20. This transaction was executed in multiple trades at prices ranging from $603.63 to $603.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

	/s/ John S. Hess, Jr. under Power of Attorney	03/31/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did UTHR CFO James Edgemond do in this Form 4 filing?

United Therapeutics CFO James Edgemond exercised options for 10,000 shares, then sold 10,000 shares in multiple open-market trades. The transactions reflect an exercise-and-sell pattern under a pre-arranged Rule 10b5-1 trading plan.

At what price did the UTHR CFO exercise his stock options?

He exercised stock options at an exercise price of $135.42 per share. This converted 10,000 options into 10,000 shares of United Therapeutics common stock before those shares were subsequently sold in the market.

What prices were United Therapeutics shares sold for in this Form 4?

The 10,000 United Therapeutics shares were sold in multiple trades at open-market prices generally between about $581.73 and $606.53 per share. Several trades used weighted average prices within narrower intraday ranges.

How many United Therapeutics shares does the CFO hold after these transactions?

Following the reported transactions, CFO James Edgemond directly owns 18,876 shares of United Therapeutics common stock. This figure reflects his position after exercising options and selling 10,000 shares in the open market.

Does the UTHR Form 4 indicate the trades were under a Rule 10b5-1 plan?

Yes. A footnote states the option exercise and subsequent share sales were executed under a Rule 10b5-1 trading plan entered on October 31, 2025. Such pre-set plans schedule trades in advance of execution.

What stock option holdings remain for the UTHR CFO after this Form 4?

After the reported option exercise, CFO James Edgemond holds 132,500 stock options. This indicates he retains a substantial derivative stake in United Therapeutics in addition to his 18,876 directly owned shares.